+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neurological Drug"

Neurological Disorder Drugs Market Report 2024 - Product Thumbnail Image

Neurological Disorder Drugs Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
From
Rare Neurological Disease Treatment Market Report 2025 - Product Thumbnail Image

Rare Neurological Disease Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Neurologic Disorders Therapeutics Market 2024-2028 - Product Thumbnail Image

Neurologic Disorders Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Episodic Ataxia Treatment Market Report 2024 - Product Thumbnail Image

Episodic Ataxia Treatment Market Report 2024

  • Report
  • October 2024
  • 175 Pages
  • Global
From
Modified Release Neurology Therapeutics - Product Thumbnail Image

Modified Release Neurology Therapeutics

  • Report
  • January 2024
  • 125 Pages
  • Global
From
5-HT1 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

5-HT1 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
Tardive Dyskinesia Treatment Market 2024-2028 - Product Thumbnail Image

Tardive Dyskinesia Treatment Market 2024-2028

  • Report
  • November 2023
  • 147 Pages
  • Global
From
Cerebral Palsy - Pipeline Review, H2 2020 - Product Thumbnail Image

Cerebral Palsy - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 50 Pages
  • Global
From
Loading Indicator

The Neurological Drug market is composed of drugs used to treat diseases and disorders of the Central Nervous System (CNS). These drugs are used to treat a wide range of conditions, including Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, and stroke. CNS drugs are also used to treat psychiatric disorders, such as depression, anxiety, and schizophrenia. These drugs are typically administered orally, intravenously, or intramuscularly. The Neurological Drug market is highly competitive, with many large pharmaceutical companies competing for market share. Companies such as Pfizer, Merck, Novartis, and GlaxoSmithKline are some of the major players in the market. Other companies, such as Eli Lilly, AstraZeneca, and Sanofi, also have a presence in the market. Additionally, there are many smaller companies that specialize in the development and manufacture of CNS drugs. Show Less Read more